FDA panel to weigh revoking key use of Abbott drug
Tuesday, May 17, 2011 - 12:30
in Health & Medicine
(AP) -- A panel of advisers to the Food and Drug Administration will consider this week whether to revoke a key indication from Abbott's blockbuster cholesterol drug Trilipix.
